National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 5) (PB 53 of 2014)

Link to law: https://www.comlaw.gov.au/Details/F2014L01063

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
PB 53 of 2014
National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 5)
National Health Act 1953
I, PAUL CREECH, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 14 July 2014
 
 
 
 
 
 
 
 
 
PAUL CREECH
First Assistant Secretary (Acting)
Pharmaceutical Benefits Division
Department of Health
 
1          Name of Instrument
            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2014 (No. 5).
            (2)        This Instrument may also be cited as PB 53 of 2014.
2          Commencement
            This Instrument commences on 1 August 2014.
3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1     Amendments
 
[1] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 25]
omit from the column headed “Claimed Price”:          12.79     substitute:             12.93
[2] Schedule 1, entry for Aciclovir in the form Tablet 200 mg [Pricing Quantity/Pack Quantity: 90]
omit from the column headed “Claimed Price”:          44.29     substitute:             44.70
[3] Schedule 1, entry for Aciclovir in the form Tablet 800 mg
omit from the column headed “Claimed Price”:          52.70     substitute:             52.89
[4] Schedule 1, entry for Amlodipine in the form Tablet 5 mg (as besylate)
omit from the column headed “Claimed Price”:          3.77        substitute:             5.92
[5] Schedule 1, entry for Amlodipine in the form Tablet 10 mg (as besylate)
omit from the column headed “Claimed Price”:          5.99        substitute:             9.16
[6] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
omit from the column headed “Claimed Price”:          2.91        substitute:             3.44
[7] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
omit from the column headed “Claimed Price”:          3.62        substitute:             4.28
[8] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          2.82        substitute:             3.35
[9] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          3.11        substitute:             3.68
[10]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”:          3.34        substitute:             3.90
[11]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL
omit from the column headed “Claimed Price”:          4.72        substitute:             5.51
[12]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 500 mg amoxycillin (as trihydrate)
omit from the column headed “Claimed Price”:          4.94        substitute:             5.75
[13]         Schedule 1, entry for Amoxycillin with Clavulanic Acid in the form Tablet containing 875 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate)
omit from the column headed “Claimed Price”:          6.56        substitute:             7.63
[14]         Schedule 1, after entry for Bupropion
insert:
Candesartan
Tablet containing candesartan cilexetil 4 mg
Oral
Atacand
30
1.71
3.33

 
Tablet containing candesartan cilexetil 8 mg
Oral
Atacand
30
5.11
6.72

 
Tablet containing candesartan cilexetil 16 mg
Oral
Atacand
30
15.28
16.90

 
Tablet containing candesartan cilexetil 32 mg
Oral
Atacand
30
18.47
20.09

Candesartan with Hydrochlorothiazide
Tablet containing candesartan cilexetil 16 mg with hydrochlorothiazide 12.5 mg
Oral
Atacand Plus 16/12.5
30
16.79
18.41

 
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 12.5 mg
Oral
Atacand Plus 32/12.5
30
19.98
21.60

 
Tablet containing candesartan cilexetil 32 mg with hydrochlorothiazide 25 mg
Oral
Atacand Plus 32/25
30
21.49
23.11

[15]         Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          6.10        substitute:             6.91
[16]         Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”:          6.42        substitute:             7.27
[17]         Schedule 1, entry for Cefaclor in the form Tablet (sustained release) 375 mg (as monohydrate)
omit from the column headed “Claimed Price”:          7.88        substitute:             8.92
[18]         Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)
omit from the column headed “Claimed Price”:          3.86        substitute:             4.41
[19]         Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)
omit from the column headed “Claimed Price”:          5.93        substitute:             6.73
[20]         Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          4.35        substitute:             4.95
[21]         Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”:          5.86        substitute:             6.66
[22]         Schedule 1, entry for Citalopram
omit from the column headed “Claimed Price”:          3.97        substitute:             6.03
[23]         Schedule 1, entry for Clindamycin
omit from the column headed “Claimed Price”:          11.89     substitute:             12.43
[24]         Schedule 1, entry for Doxepin in the form Capsule 10 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          4.41        substitute:             5.14
[25]         Schedule 1, entry for Doxepin in the form Capsule 25 mg (as hydrochloride)
omit from the column headed “Claimed Price”:          4.51        substitute:             5.14
[26]         Schedule 1, entry for Doxycycline
substitute:
Doxycycline
Capsule 100 mg (as hydrochloride) (containing enteric coated pellets)
Oral
Doryx
7
1.03
2.93

 
 
 
Mayne Pharma Doxycycline
7
1.03
1.83

 
 
 
Doryx
21
-
7.54

 
 
 
Mayne Pharma Doxycycline
21
-
4.91

 
Capsule 50 mg (as hydrochloride) (containing enteric coated pellets)
Oral
Doryx
25
1.83
5.01

 
 
 
Mayne Pharma Doxycycline
25
1.83
3.15

[27]         Schedule 1, entry for Escitalopram in the form Capsule 10 mg (as oxalate)
omit from the column headed “Claimed Price”:          7.12        substitute:             9.53
[28]         Schedule 1, entry for Escitalopram in the form Capsule 20 mg (as oxalate)
omit from the column headed “Claimed Price”:          8.27        substitute:             10.31
[29]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg
omit from the column headed “Claimed Price”:          8.13        substitute:             9.53
[30]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg
omit from the column headed “Claimed Price”:          11.59     substitute:             12.99
[31]         Schedule 1, entry for Frusemide in the form Tablet 20 mg
omit from the column headed “Claimed Price”:          1.37        substitute:             1.49
[32]         Schedule 1, entry for Frusemide in the form Tablet 40 mg
omit from the column headed “Claimed Price”:          2.93        substitute:             3.25
[33]         Schedule 1, entry for Glipizide
omit from the column headed “Claimed Price”:          7.83        substitute:             8.38
[34]         Schedule 1, entry for Indomethacin
omit from the column headed “Claimed Price”:          3.43        substitute:             4.31
[35]         Schedule 1, after entry for Labetalol in the form Tablet containing labetalol hydrochloride 200 mg
insert:
Lactulose
Solution BP 3.34 g per 5 mL, 500 mL
Oral
Actilax
1
3.19
3.91
[36]         Schedule 1, entry for Lamotrigine in the form Tablet 5 mg
omit from the column headed “Claimed Price”:          5.24        substitute:             6.11
[37]         Schedule 1, entry for Lamotrigine in the form Tablet 25 mg
omit from the column headed “Claimed Price”:          10.44     substitute:             12.16
[38]         Schedule 1, entry for Lamotrigine in the form Tablet 50 mg
omit from the column headed “Claimed Price”:          16.88     substitute:             18.14
[39]         Schedule 1, entry for Lamotrigine in the form Tablet 100 mg
omit from the column headed “Claimed Price”:          27.23     substitute:             28.70
[40]         Schedule 1, entry for Lamotrigine in the form Tablet 200 mg
omit from the column headed “Claimed Price”:          45.02     substitute:             46.51
[41]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg
omit from the column headed “Claimed Price”:          4.66        substitute:             5.73
[42]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg
omit from the column headed “Claimed Price”:          6.59        substitute:             7.66
[43]         Schedule 1, entry for Medroxyprogesterone in the form Injection containing medroxyprogesterone acetate 150 mg in 1 mL
(a)   omit from the column headed “Determined Price”:             12.03     substitute:             13.14
(b)   omit from the column headed “Claimed Price”:                  14.61     substitute:             15.97
[44]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 5 mg
(a)   omit from the column headed “Determined Price”:             6.69        substitute:             7.44
(b)   omit from the column headed “Claimed Price”:                  8.27        substitute:             9.53
[45]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 30]
omit from the column headed “Claimed Price”:          7.97        substitute:             8.38
[46]         Schedule 1, entry for Medroxyprogesterone in the form Tablet containing medroxyprogesterone acetate 10 mg [Pricing Quantity/Pack Quantity: 100]
omit from the column headed “Claimed Price”:          22.88     substitute:             23.34
[47]         Schedule 1, entry for Meloxicam in the form Capsule 7.5 mg
omit from the column headed “Claimed Price”:          5.98        substitute:             6.98
[48]         Schedule 1, entry for Meloxicam in the form Capsule 15 mg
omit from the column headed “Claimed Price”:          8.25        substitute:             9.24
[49]         Schedule 1, entry for Meloxicam in the form Tablet 7.5 mg
omit from the column headed “Claimed Price”:          5.98        substitute:             6.98
[50]         Schedule 1, entry for Meloxicam in the form Tablet 15 mg
omit from the column headed “Claimed Price”:          8.25        substitute:             9.24
[51]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
omit from the column headed “Claimed Price”:          4.01        substitute:             4.66
[52]         Schedule 1, after entry for Metformin in the form Tablet containing metformin hydrochloride 500 mg
insert in the columns in the order indicated:
 
Tablet (extended release) containing metformin hydrochloride 500 mg
Oral
Diabex XR
120
5.06
6.56
[53]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 850 mg [Brand: Diabex 850]
omit from the column headed “Claimed Price”:          4.01        substitute:             4.66
[54]         Schedule 1, entry for Metformin in the form Tablet containing metformin hydrochloride 1 g
omit from the column headed “Claimed Price”:          6.38        substitute:             7.00
[55]         Schedule 1, omit entry for Norethisterone
[56]         Schedule 1, entry for Paroxetine
omit from the column headed “Claimed Price”:          6.78        substitute:             7.64
[57]         Schedule 1, after entry for Paroxetine
insert:
Perindopril
Tablet containing perindopril arginine 2.5 mg
Oral
Coversyl 2.5mg
30
2.74
4.32

 
 
 
PREXUM 2.5
30
2.74
4.32

[58]         Schedule 1, entry for Piroxicam in the form Capsule 10 mg
omit from the column headed “Claimed Price”:          6.72        substitute:             7.16
[59]         Schedule 1, entry for Piroxicam in the form Capsule 20 mg
omit from the column headed “Claimed Price”:          6.46        substitute:             6.76
[60]         Schedule 1, entry for Piroxicam in the form Dispersible tablet 20 mg
omit from the column headed “Claimed Price”:          6.84        substitute:             7.57
[61]         Schedule 1, entry for Prochlorperazine
omit from the column headed “Claimed Price”:          3.71        substitute:             4.26
[62]         Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30
omit from the column headed “Claimed Price”:          4.14        substitute:             4.20
[63]         Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30
omit from the column headed “Claimed Price”:          4.34        substitute:             4.38
[64]         Schedule 1, entry for Spironolactone in the form Tablet 25 mg
omit from the column headed “Claimed Price”:          6.08        substitute:             6.76
[65]         Schedule 1, entry for Spironolactone in the form Tablet 100 mg
omit from the column headed “Claimed Price”:          20.30     substitute:             20.92
[66]         Schedule 1, entry for Sulfasalazine
omit from the column headed “Claimed Price”:          21.06     substitute:             21.27
[67]         Schedule 1, entry for Sumatriptan
omit from the column headed “Claimed Price”:          5.14        substitute:             5.87
[68]         Schedule 1, after entry for Sumatriptan in the form Tablet 50 mg (as succinate)
insert in the columns in the order indicated:
 
Tablet (fast disintegrating) 50 mg (as succinate)
Oral
Imigran FDT
2
4.66
5.87
[69]         Schedule 1, omit entry for Telmisartan
[70]         Schedule 1, omit entry for Telmisartan with Hydrochlorothiazide
[71]         Schedule 1, entry for Tinidazole
omit from the column headed “Claimed Price”:          5.49        substitute:             5.96
[72]         Schedule 1, entry for Tramadol in the form Capsule containing tramadol hydrochloride 50 mg
omit from the column headed “Claimed Price”:          2.76        substitute:             3.04
[73]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 100 mg
omit from the column headed “Claimed Price”:          6.05        substitute:             6.59
[74]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 150 mg
omit from the column headed “Claimed Price”:          7.66        substitute:             8.32
[75]         Schedule 1, entry for Tramadol in the form Tablet (sustained release) containing tramadol hydrochloride 200 mg
omit from the column headed “Claimed Price”:          9.03        substitute:             9.77
[76]         Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 200 mg
omit from the column headed “Claimed Price”:          8.20        substitute:             8.37
[77]         Schedule 1, entry for Valproic Acid in the form Tablet (enteric coated) containing sodium valproate 500 mg
omit from the column headed “Claimed Price”:          15.70     substitute:             15.89
[78]         Schedule 2, omit entry for Telmisartan